2021 to 2022 saw decrease in age-adjusted death rate in US
May 04, 2023
The highest overall death rates were seen for persons aged 85 years and older, non-Hispanic American Indian or Alaska Natives, non-Hispanic Black or African Americans, and males.
Nirmatrelvir cuts risk for post-COVID-19 condition
Mar 27, 2023
The findings were seen regardless of vaccination status and history of prior infection.
Incident CVD, mortality risk heightened for at least one year after COVID-19
Feb 21, 2023
Short- and long-term risks were found in a large study of patients with COVID-19 versus matched contemporary and historical cohorts.
New-onset a-fib profiled in patients hospitalized with COVID-19
Sep 28, 2022
New-onset atrial fibrillation was identified in about one in 20 patients hospitalized with COVID-19.
For many, myocarditis risk higher after SARS-CoV-2 infection than vaccination
Aug 23, 2022
But the myocarditis risk was higher after vaccination for men younger than age 40 years, particularly after the second dose of mRNA-1273.
ACC offers guidance on cardiovascular sequelae of COVID-19
Mar 18, 2022
The guidelines address myocarditis and other types of myocardial involvement, postacute sequelae of SARS-CoV-2 and return to exercise.
2019 to 2020 saw 16.8 percent increase in U.S. death rate
Dec 22, 2021
The two leading causes of death continued to be heart disease and cancer, with COVID-19 the third leading cause of death in 2020.
Monoclonal antibody therapy may cut COVID-19 hospitalizations
Aug 31, 2021
Lower hospitalization rates were seen at 14, 21 and 28 days for high-risk patients with mild-to-moderate COVID-19 who received casirivimab-imdevimab.
Modifiable cardiovascular risk factors linked to severity of COVID-19
Jun 16, 2021
Strategies that improve cardiovascular health also may improve outcomes for people following COVID-19.
COVID-19 vaccine priority populations vary by state, city: reports
By
Kimberly Bonvissuto
Dec 11, 2020
With the Food and Drug Administration’s vaccine advisory board recommending approval of the Pfizer-BioNTech COVID-19 vaccine for emergency use authorization on Thursday, two data analyses outline which...